Investors in United Therapeutics Corp (Symbol: UTHR) saw new options become available this week, for the November 21st expiration. One of the key inputs that goes into the price an option buyer is ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 20.19%, which has investors questioning if this is right time to ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Therapeutics ... history, with the $380 strike highlighted in orange: Atlassian ...

Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp Jeffrey Creech; Chief Financial Officer, Executive Vice President; 3D Systems Corp Greetings, and welcome to the 3D ...

Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose ...

D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2024. Full-year 2024 ...

Dandelion Energy, the nation's leading home geothermal heating and cooling company, today announced they are partnering with Lennar Corporation , one of the nation's leading homebuilders, on one of ...

Forbes released the annual World’s Billionaires list. Dangote, the founder and CEO of the Dangote Group, the largest ...

MacroGenics, Inc.’s MGNX share price has dipped by 14.19%, which has investors questioning if this is right time to buy.

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...

owned by United Therapeutics Corp. The demand for organs is huge. More than 100,000 Americans are on waiting lists for donor organs, most needing a kidney. Only 25,000 human donor kidneys become ...

I've heard stories of hardship and triumph alike, all of which I'm proud to celebrate during this Women's History ... from the United States Patent and Trademark Office (USPTO) for a new patent ...